Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Samsara BioCapital, L.P.
Shares: 0.00 · Class: 0.0%
- Samsara BioCapital GP, LLC
Shares: 0.00 · Class: 0.0%
- Srinivas Akkaraju
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021974
- Form type
- SCHEDULE 13G/A
- Filer
- OnKure Therapeutics, Inc.
- CIK
- CIK 1637715
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership